Suggestions appear as you type. Use the up and down arrows to choose one and Enter to open it.

This page's audience real numbers from our own analytics — open to see them
–Visitors
–Page views
–Clicks to vendors
–Time on page
–Reading now
Clicks to vendors, by tool
  • –
Top countries
  • –
Devices
  • –

– · counted by iTechGuides's own first-party analytics, bots removed, every figure rounded down · how we count

Standigm STELLA

#23 of 30 in AI Drug Discovery Software

Standigm STELLA: A focused cloud workspace for constrained candidate design and hit-to-lead optimization. Ranked #23 of 30 in AI Drug Discovery Software by our editors (6.0/10); pricing: 14-day trial; best for teams optimizing small-molecule hits and leads.

6.0/10Editor score
Standigm STELLA6.0 Try Standigm STELLA

At a glance

  • Editor score
    6.0 / 10
  • Pricing
    14-day trial
  • Best for
    Teams optimizing small-molecule hits and leads
  • Free plan
    No
  • Paid from
    $2,500/mo
  • Target identification
    No
  • Founded
    2015 · Seoul, Republic of Korea
  • Facts checked
    4 Oct 2026
  • Where it wins

    • Generates candidates with scaffold constraints and multiple objectives
    • Combines docking, binding-mode analysis, scoring, and 3D pose views
    • Supports iterative design with user feedback and project history
  • Where it doesn't

    • Molecule-focused scope excludes target identification and drug repurposing
    • Monthly plans start at $2,500
    • Web-based cloud deployment may not fit teams requiring other deployment options

Our verdict on Standigm STELLA

Standigm STELLA is a cloud-based molecular design and hit-to-lead optimization workspace for drug-discovery teams, including medicinal chemists refining small-molecule candidates. It can generate compounds against selected pharmaceutical objectives, including activity and ADMET-related properties, while keeping a chosen scaffold. Teams can review candidate clusters and rankings, compare binding poses with a reference compound, and guide iterative design episodes with project data and feedback. The product is focused on molecule design rather than target identification or drug repurposing.

The published monthly plans show three fixed tiers: 1 token costs $2,500 per month, 2 tokens costs $4,500 per month, and 3 tokens costs $6,000 per month. Each includes scaffold-locked generation, automated binding-mode analysis, multi-parameter scoring, 3D pose visualization, a molecule library, and project history. A 14-day free trial is available without a credit card. The 4+ tokens tier lists unlimited parallel tasks, a dedicated account manager, custom integrations, an SLA, and enterprise security; its price is not stated here. This structure gives teams a way to expand token capacity, while the entry plan represents a substantial monthly commitment.

STELLA’s strongest fit is a workflow where candidate generation, docking analysis, property scoring, and medicinal-chemist review need to inform one another. Selected candidates can be exported to Excel, and the platform runs in the cloud through a web interface. For teams looking for target identification or repurposing, STELLA is not the relevant part of Standigm’s portfolio; those capabilities are described separately. Teams wanting a molecule-centered workflow for constrained hit-to-lead iteration may find the scope appropriate, while groups seeking a broader discovery platform should consider alternatives with those capabilities.

Your product? Our editors can test Standigm STELLA in depth and publish a review, labelled as paid · from $99/mo →

Standigm STELLA pricing

Plans 14-day trial No free plan — trial or paid only. Prices checked 4 Oct 2026.
See plans on standigm.com

All 4 Standigm STELLA plans and prices →

Standigm STELLA fact sheet

Free planNo
Paid from$2,500/mo
Target identificationNo
Molecule designYes
Drug repurposingNo
Discovery scopeMolecule
Deployment optionsCloud
Research publicationsYes
Free trial14 days · no card needed
DeploymentCloud
PlatformsWeb
SupportEmail
Built forSmall business, Mid-market, Enterprise (editorial estimate)
Pricing14-day trial (source)
Websitestandigm.com
Facts checked4 Oct 2026

Alternatives to Standigm STELLA

See all Standigm STELLA alternatives →

Used Standigm STELLA? Be the first to review it

The editor score above is our own research. What this page doesn't have yet is a reader's view — what you used Standigm STELLA for, what worked and what didn't. No stars are seeded and no review is paid for; an editor reads every one before it appears.

Write a reviewTwo minutes · verified accounts only · read by an editor before it appears

Reviews come only from verified accounts. Sign in or create an account first — your e-mail is never shown.

Your rating

0 characters · at least 80, up to 3,000

Posted from your verified account. Reviews appear after an editor reads them, usually within two working days.

Featured on iTechGuides

Featured on iTechGuides — Standigm STELLA 6.0/10

Standigm STELLA is listed in our AI Drug Discovery Software directory. Add the badge to your site — it links back to this page.

<a href="https://www.itechguides.com/products/standigm-stella/"><img src="https://www.itechguides.com/best/badge/standigm-stella.svg" alt="Featured on iTechGuides" width="230" height="46"></a>

Reviewed by iTechGuides Editors · Editorial team · Updated Oct 2026

Advertiser disclosure: iTechGuides is reader-supported. Vendors can pay for top positions in our rankings and for a place on other products' pages, and we may earn a commission when you click some links. How we rank.

Last updated · How we research and update